C-Circle – “Managing Working Capital – How Smart Companies Survive and Prosper”

Date: Thursday, May 21, 2015
Time: 8:00am-10:00am
Location: Morgan Lewis
3000 El Camino Real
Two Palo Alto Square, 6th Floor
Palo Alto, CA 94304


Are you a CEO or other C-level executive and wish to request to be part of these events?

 

The ACG Silicon Valley C-Circle, now in its fifth year, proudly announces that it has attracted a following of approximately 250 CEOs and C-Level Executives and achieved a regular attendance of 35 executives per session.

Topics

The topic for our next meeting is “Managing Working Capital – How Smart Companies Survive and Prosper.”

We have all heard the phrase that “Cash is King.”  Accordingly, good financial and working capital management is critical to the success of any business, but it is particularly important to growing technology companies where the risk of insolvency is often little more than an unpaid invoice away.  In the race to introduce products into the market, ramp up sales and beat the competition, insufficient attention may be paid to the cash flow necessary to fund these activities.

Please join us for an enlightening discussion on the following questions:

  • What are the key elements of working capital management?
  • How does a company optimize its working capital?
  • How does a company allocate scarce capital resources among competing demands, all of which are important?
  • How does a company manage its working capital to pursue its business plan as well as be opportunistic?
  • How does one instill financial discipline in a rapidly growing company?
  • When is the right time to hire a CFO?
  • How does one know it has the right CFO?
  • What is the cash conversion cycle and how can it be optimized?
  • What is the relationship between working capital management and profitability?
  • Do incentives and penalties work in speeding up cash conversion?
  • How does the development of financial systems and cash controls evolve with the growth of the business?
  • How does working capital management affect valuation for purposes of fundraising or an M&A transaction?
  • What are the key principles that every fast growing company should know about working capital management?

OUR DISTINGUISHED SPEAKERS

Kim Le

CEO,
A2Q2

Kim is the founder and CEO of A2Q2 a provider of innovative process and system solutions to high-growth companies to solve complex needs. As a Special Ops team to finance departments, A2Q2 specializes in data analytics, IPO readiness, NetSuite consulting, and SOX compliance. Its clients included leading companies like Airbnb, Clorox, CNET, EventBrite, Pandora, Plantronics, Square, Stanford University, Uber and Verifone.

Kim has over 20 years of experience in accounting and auditing. She has led IPO readiness, SOX compliance, financial statement audits, internal audits, financial restatements and ERP implementations. Kim started her public accounting career with Arthur Andersen until May 2002 when the firm imploded. In 2003, Kim took the entrepreneurial plunge while five months pregnant with her second child and founded A2Q2. She has been recognized as one of the 100 Most Influential Women by Silicon Valley Business Journal (2013). In her spare time, she crashes motorcycles and runs Tough Mudder events.

Linda Rubinstein

Partner,
FLG Partners

FLG, a firm of 24 CFOs, is engaged by companies, their boards and investors to provide CFO leadership on a permanent, full time, part time, or project basis, from A-round private companies to billion-dollar public ones, mostly in the tech and life sciences sectors.  A partner in FLG since 2010, Linda has over 25 years of operational, financial and capital markets experience in life sciences, software and investment banking.  She has built particular expertise in life sciences, notably biotechnology, life science tools and diagnostics.  As CPO, Linda has overseen finance at research-and commercial-stage enterprises, consummated financing and M&A transactions, contributed to operations and strategy, and worked at private and public companies.  These include ChemoCentryx, Ingenuity Systems (sold to QIAGEN), iPierian (sold to BMS), Medallia, Retrotope, Solexa (sold to Illumina), True North Therapeutics and Tunitas.  As an investment banker, Linda completed over 30 transactions, raising over $5 billion in capital for companies ranging from emerging start-ups to Fortune 500 companies.

 

Are you a CEO or other C-level executive and wish to request to be part of these events?